Matches in SemOpenAlex for { <https://semopenalex.org/work/W2551960109> ?p ?o ?g. }
- W2551960109 endingPage "50" @default.
- W2551960109 startingPage "42" @default.
- W2551960109 abstract "Brentuximab vedotin (BV) is an antibody-drug conjucate (ADC) comprising a CD30-directed antibody, conjugated to the microtubule-disrupting agent MMAE via a protease cleavable linker. BV is FDA approved for use in relapsed classical Hodgkin lymphoma (HL) and relapsed systemic anaplastic large cell lymphoma (sALCL). There are multiple publications for its utility in other malignancies such as diffuse large B-cell lymphoma (DLBCL), mycosis fungoides (MF), Sézary syndrome (SS), T-cell lymphomas (TCL), primary mediastinal lymphoma (PMBL), and post-transplant lymphoproliferative disorders (PTLD). We believe that BV could potentially provide a strong additional treatment option for patients suffering from NHL. Perform a systematic review on the use of BV in non-Hodgkin lymphoma (NHL) and other CD30+ malignancies in humans. We searched various databases including PubMed (1946–2015), EMBASE (1947–2015), and Cochrane Central Register of Controlled Trials (1898–2015). Inclusion criteria specified all studies and case reports of NHLs in which BV therapy was administered. A total of 28 articles met these criteria and are summarized in this manuscript. Our findings indicate that BV induces a variety of responses, largely positive in nature and variable between NHL subtypes. With additional, properly powered prospective studies, BV may prove to be a strong candidate in the treatment of various CD30+ malignancies." @default.
- W2551960109 created "2016-11-30" @default.
- W2551960109 creator A5001841017 @default.
- W2551960109 creator A5011096418 @default.
- W2551960109 creator A5022138551 @default.
- W2551960109 creator A5049387929 @default.
- W2551960109 creator A5057263496 @default.
- W2551960109 creator A5062126838 @default.
- W2551960109 creator A5063270861 @default.
- W2551960109 creator A5066006911 @default.
- W2551960109 creator A5069294145 @default.
- W2551960109 creator A5081784775 @default.
- W2551960109 date "2017-01-01" @default.
- W2551960109 modified "2023-09-25" @default.
- W2551960109 title "Brentuximab vedotin for treatment of non-Hodgkin lymphomas: A systematic review" @default.
- W2551960109 cites W141670340 @default.
- W2551960109 cites W144665287 @default.
- W2551960109 cites W1566675189 @default.
- W2551960109 cites W1605149682 @default.
- W2551960109 cites W1764703361 @default.
- W2551960109 cites W1777349922 @default.
- W2551960109 cites W1964466646 @default.
- W2551960109 cites W1972866849 @default.
- W2551960109 cites W1977717018 @default.
- W2551960109 cites W1987396645 @default.
- W2551960109 cites W1989216770 @default.
- W2551960109 cites W1994401253 @default.
- W2551960109 cites W2010988457 @default.
- W2551960109 cites W2011118089 @default.
- W2551960109 cites W2011686177 @default.
- W2551960109 cites W2015397586 @default.
- W2551960109 cites W2018571205 @default.
- W2551960109 cites W2019770817 @default.
- W2551960109 cites W2021330461 @default.
- W2551960109 cites W2027324105 @default.
- W2551960109 cites W2032251969 @default.
- W2551960109 cites W2032691455 @default.
- W2551960109 cites W2032713012 @default.
- W2551960109 cites W2037524923 @default.
- W2551960109 cites W2043715601 @default.
- W2551960109 cites W2046282385 @default.
- W2551960109 cites W2054395129 @default.
- W2551960109 cites W2055342008 @default.
- W2551960109 cites W2060466778 @default.
- W2551960109 cites W2061337936 @default.
- W2551960109 cites W2073983698 @default.
- W2551960109 cites W2074829227 @default.
- W2551960109 cites W2075280221 @default.
- W2551960109 cites W2088824803 @default.
- W2551960109 cites W2102117057 @default.
- W2551960109 cites W2129207909 @default.
- W2551960109 cites W2139891818 @default.
- W2551960109 cites W2141170317 @default.
- W2551960109 cites W2145174107 @default.
- W2551960109 cites W2147187798 @default.
- W2551960109 cites W2149997323 @default.
- W2551960109 cites W2155256323 @default.
- W2551960109 cites W2159230880 @default.
- W2551960109 cites W2159332670 @default.
- W2551960109 cites W2179483502 @default.
- W2551960109 cites W2187112254 @default.
- W2551960109 cites W2229592961 @default.
- W2551960109 cites W2241188447 @default.
- W2551960109 cites W2284818858 @default.
- W2551960109 cites W2397806837 @default.
- W2551960109 cites W2546775295 @default.
- W2551960109 cites W2559295956 @default.
- W2551960109 cites W2979542832 @default.
- W2551960109 doi "https://doi.org/10.1016/j.critrevonc.2016.11.009" @default.
- W2551960109 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5218629" @default.
- W2551960109 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28010897" @default.
- W2551960109 hasPublicationYear "2017" @default.
- W2551960109 type Work @default.
- W2551960109 sameAs 2551960109 @default.
- W2551960109 citedByCount "57" @default.
- W2551960109 countsByYear W25519601092017 @default.
- W2551960109 countsByYear W25519601092018 @default.
- W2551960109 countsByYear W25519601092019 @default.
- W2551960109 countsByYear W25519601092020 @default.
- W2551960109 countsByYear W25519601092021 @default.
- W2551960109 countsByYear W25519601092022 @default.
- W2551960109 countsByYear W25519601092023 @default.
- W2551960109 crossrefType "journal-article" @default.
- W2551960109 hasAuthorship W2551960109A5001841017 @default.
- W2551960109 hasAuthorship W2551960109A5011096418 @default.
- W2551960109 hasAuthorship W2551960109A5022138551 @default.
- W2551960109 hasAuthorship W2551960109A5049387929 @default.
- W2551960109 hasAuthorship W2551960109A5057263496 @default.
- W2551960109 hasAuthorship W2551960109A5062126838 @default.
- W2551960109 hasAuthorship W2551960109A5063270861 @default.
- W2551960109 hasAuthorship W2551960109A5066006911 @default.
- W2551960109 hasAuthorship W2551960109A5069294145 @default.
- W2551960109 hasAuthorship W2551960109A5081784775 @default.
- W2551960109 hasBestOaLocation W25519601092 @default.
- W2551960109 hasConcept C121608353 @default.
- W2551960109 hasConcept C126322002 @default.
- W2551960109 hasConcept C143998085 @default.
- W2551960109 hasConcept C159654299 @default.